PAMS
PACB icon

Pictet Asset Management (Switzerland)’s Pacific Biosciences PACB Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$359K Buy
27,025
+3,692
+16% +$44.9K ﹤0.01% 1414
2023
Q1 		$270K Hold
23,333
– – ﹤0.01% 1561
2022
Q4 		$191K Buy
23,333
+10,933
+88% +$94.2K ﹤0.01% 1745
2022
Q3 		$72K Hold
12,400
– – ﹤0.01% 1500
2022
Q2 		$55K Sell
12,400
-118,320
-91% -$719K ﹤0.01% 1533
2022
Q1 		$1.19M Hold
130,720
– – ﹤0.01% 1037
2021
Q4 		$2.67M Sell
130,720
-538,440
-80% -$13M ﹤0.01% 957
2021
Q3 		$17.1M Buy
+669,160
New +$19.8M 0.02% 550

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s PACB Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) increased its Pacific Biosciences (PACB) stake by 16% in Q2 2023, buying an estimated $44.9K and bringing the position to 27,025 shares worth $359K. The position accounts for ﹤0.01% of the portfolio, ranked #1414.

Pictet Asset Management (Switzerland) first reported a position in PACB in Q3 2021 and has held it in 8 quarters since. The position peaked at $17.1M in Q3 2021. 272 funds tracked by Wall St. Rank hold PACB as of Q2 2023.

  • Pictet Asset Management (Switzerland) held 27,025 shares of Pacific Biosciences worth $359K as of Q2 2023.
  • Pictet Asset Management (Switzerland) bought 3,692 Pacific Biosciences shares in Q2 2023, an estimated $44.9K.
  • Pacific Biosciences made up ﹤0.01% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #1414 holding.
  • Pictet Asset Management (Switzerland) first reported a position in Pacific Biosciences in Q3 2021 and has held it in 8 quarters since.
  • Pictet Asset Management (Switzerland)'s Pacific Biosciences position peaked at $17.1M in Q3 2021.
  • 272 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.